Benzinga | Feb 1, 2021 04:02PM EST

Vertex Pharmaceuticals Q4 Adj. EPS $2.30 Misses $2.59 Estimate, Sales $1.63B Beat $1.58B Estimate

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $2.30 per share which missed the analyst consensus estimate of $2.59 by 11.2 percent. This is a 35.29 percent increase over earnings of $1.70 per share from the same period last year. The company reported quarterly sales of $1.63 billion which beat the analyst consensus estimate of $1.58 billion by 3.16 percent. This is a 29.67 percent increase over sales of $1.26 billion the same period last year.